RUNX2 and T-cell non-Hodgkin lymphoma: Interestingly, lesions were positive for MYC (Fig. 6E; n=4), which has been shown previously to act cooperatively with RUNX2 to drive T-cell lymphoma (Blyth et al., 2006).